ICUNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICUCW

SeaStar Medical Holding Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$3.11+0.21 (+7.24%)

Close on Oct 19, 2026

Market cap: $12.70M
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Jun 30, 2026

SeaStar Medical reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in SeaStar Medical's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in SeaStar Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Mar 25, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ICU.

Revenue growth123.6% · median 44.6%

Gross margin92.6% · median 35.3%

Operating margin-816.6% · median -685.2%

Net margin-795.5% · median -651.1%

Company	Revenue	Growth
AURX	$5.20M	+166.6%
RNXT	$1.98M	–
OSRH	$1.81M	-50.2%
ICU	$1.71M	+123.6%
PLSE	$1.19M	–
HRGN	$982.00K	+44.6%

Company

Next earnings (est.): Nov 12, 2026, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 17
Auditor: WithumSmith+Brown, PC
SEC CIK: 1831868

Advertisement
300 × 250